News Conference News AHA 2024 US Obesity Epidemic Continues to Skyrocket, With No End in Sight Michael O'Riordan November 15, 2024
News Conference News AHA 2016 En mitad de la Marea Creciente de ECVA, los Costes del Tratamiento Deberían hacer que los Legisladores Legislasen en Materia de Prevención Yael L. Maxwell November 29, 2016
News Conference News AHA 2016 Amid Rising Tide of Atherosclerotic CVD, Costs of Treatment Should Spur Policy Makers to Push Prevention Yael L. Maxwell November 29, 2016
News Conference News AHA 2016 ¿Dolor Muscular Secundario a las Estatinas? Según el Análisis GAUSS-3 Podría ser Genético Michael O'Riordan November 22, 2016
News Conference News AHA 2016 Statin-Associated Muscle Pain? It May Be Your Genes, Says GAUSS-3 Analysis Michael O'Riordan November 22, 2016
News Conference News AHA 2016 Proton Pump Inhibitor Use Tied to Elevated Ischemic Stroke Risk Todd Neale November 16, 2016
News Conference News AHA 2016 Racial Differences in How Patients Perceive CVD Risk Should Spur Rethink in Management Yael L. Maxwell November 16, 2016
News Conference News AHA 2016 Dabigatran Reversal Agent’s Safety, Efficacy Affirmed With Updated Study Results Todd Neale November 15, 2016
News Conference News AHA 2016 PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad Michael O'Riordan November 15, 2016
News Conference News AHA 2016 No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION Shelley Wood November 13, 2016
News Conference News AHA 2016 Ticagrelor Fails to Best Clopidogrel in Preventing CV Events in PAD Patients Yael L. Maxwell November 13, 2016
News Conference News AHA 2016 Cardiac Arrest Survival Higher in Patients Already Taking Statins Todd Neale November 12, 2016